Literature DB >> 16011448

Drug-induced nephropathy: an update.

Mark A Perazella1.   

Abstract

Medications cause renal disease by promoting various types of injury in the kidney. Several drugs reduce renal perfusion and cause prerenal azotemia. Vascular disease can develop following exposure to various medications through direct and indirect effects. A number of glomerular lesions have been described with therapeutic agents and illicit drugs. Acute interstitial nephritis occurs from a drug-induced allergic reaction, which promotes interstitial inflammation and tubular damage. Acute tubular necrosis is a dose-dependent process that occurs from direct drug toxicity on tubular epithelia. Other less common patterns of drug-induced tubular injury include osmotic nephropathy, crystal nephropathy and acute nephrocalcinosis. Finally, postrenal azotemia from structural or functional obstruction of the urinary tract also complicates therapy with a number of medications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16011448     DOI: 10.1517/14740338.4.4.689

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  25 in total

Review 1.  Pharmacology behind Common Drug Nephrotoxicities.

Authors:  Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-05       Impact factor: 8.237

Review 2.  Drug-Induced Kidney Injury in the Elderly.

Authors:  Sana Khan; Valentina Loi; Mitchell H Rosner
Journal:  Drugs Aging       Date:  2017-10       Impact factor: 3.923

3.  Novel assays for detection of urinary KIM-1 in mouse models of kidney injury.

Authors:  Venkata S Sabbisetti; Kazumi Ito; Chang Wang; Li Yang; Stephen C Mefferd; Joseph V Bonventre
Journal:  Toxicol Sci       Date:  2012-09-27       Impact factor: 4.849

4.  Dramatic Increase of Amoxicillin-Induced Crystal Nephropathy Found in a Cohort Study of French Pharmacovigilance Centers.

Authors:  Dominique Vodovar; Laure Thomas; Nicolas Mongardon; Raphaël Lepeule; Bénédicte Lebrun-Vignes; Michel Biour; Florence Netzer; Hakim Haouache; Christine Le Beller; Gilles Dhonneur
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

5.  A comparison between the effects of ochratoxin A and aristolochic acid on the inflammation and oxidative stress in the liver and kidney of weanling piglets.

Authors:  D E Marin; G C Pistol; M Gras; M Palade; I Taranu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-22       Impact factor: 3.000

Review 6.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  Acute kidney injury: Preventing acute kidney injury through nephrotoxin management.

Authors:  Mark A Perazella; F Perry Wilson
Journal:  Nat Rev Nephrol       Date:  2016-07-04       Impact factor: 28.314

8.  Postmortem examination of the kidney in allogeneic hematopoietic stem cell transplantation recipients: possible involvement of graft-versus-host disease.

Authors:  Eiji Kusumi; Masahiro Kami; Shigeo Hara; Junichi Hoshino; Yutaka Yamaguchi; Naoko Murashige; Yukiko Kishi; Yugo Shibagaki; Taro Shibata; Tomoko Matsumura; Koichiro Yuji; Kazuhiro Masuoka; Atsushi Wake; Shigesaburo Miyakoshi; Shuichi Taniguchi
Journal:  Int J Hematol       Date:  2008-02-09       Impact factor: 2.490

9.  Nonsteroidal anti-inflammatory drugs alter vasa recta diameter via pericytes.

Authors:  Teresa Kennedy-Lydon; Carol Crawford; Scott S Wildman; Claire M Peppiatt-Wildman
Journal:  Am J Physiol Renal Physiol       Date:  2015-07-22

10.  Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Authors:  Musa Yilmaz; Amit Lahoti; Susan O'Brien; Graciela M Nogueras-González; Jan Burger; Alessandra Ferrajoli; Gautam Borthakur; Farhad Ravandi; Sherry Pierce; Elias Jabbour; Hagop Kantarjian; Jorge E Cortes
Journal:  Cancer       Date:  2015-07-28       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.